Synthesis of 2-aryl-7-(3-oxo-2H-[1,4]-benzoxazin-6-yl)pyrazolo[1,5-a] pyrimidines as potential COX-2-inhibitors

Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry

Volumn 44, Issue 1, 2005, Pages 204-206

  Reddy, G Jagath ^a   Sailaja, S ^a   Srinivasa Rao, K ^a   Reddanna, P ^b   Reddy, D Bharat ^b  

^a SVCo op Industrial Estate   (India)

^b University of Hyderabad Campus   (India)

Author keywords

[No Author keywords available]

Indexed keywords

2 (4 METHYLPHENYL) 7 (2 METHYL 3 OXO 2H [1,4]BENZOXAZIN 6 YL)PYRAZOLO[1,5 A]PYRIMIDINE; 7 (3 OXO 2H [1,4]BENZOXAZIN 6 YL)PYRAZOLO[1,5 A]PYRIMIDINE DERIVATIVE; CYCLOOXYGENASE 2 INHIBITOR; PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; INFRARED SPECTROMETRY; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; STRUCTURE ANALYSIS;

EID: 14144255284     PISSN: 03764699     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Charlier C & Michaux C, Eur J Mednl Chem, 38, 2003, 645.
2. Penning T D, Talley J J, Bertenshaw S R, Carter J S, Collins P W, Doctor S, Graneto M J, Lee L F, Malecha J W, Miyashiro J M, Rogers R S, Rogier D J, Yu S S, Anderson G D, Burton E G, Cogburn J N, Gregory S A, Koboldt C M, Perkins W E, Seibert K, Veenhuizen A W, Zhang Y Y & Isakson P C, J Med Chem, 40, 1997, 1347.
3. Almansa C, de Arriba A F, Carakanti F L, Gomez L A, Miralles A, Merlos M, Rafanell J G & Forn J, J Med Chem, 41, 2001, 350.
4. Mealy N & Castaner J, Drugs of the future, 21 (1), 1996, 37.
5. Blair K C, Castaner J & Silvestre J S, Drugs of the future, 28 (2), 2003, 115.
6. Wu J M, Chang F R, Hayashi K, Shiraki H, Liaw C C, Nakanishi Y, Bastow K F, Yu D, Chen I S & Lee K H, Bioorg Med Chem Letters, 13, 2003, 2223.
7. Chapleo C B, Batler RCM, England D, Myen P L, Ronech A G, Smith C F C, Stiuings M R & Talloch I F, J Med Chem, 32, 1989, 162.
8. a) Combs D W, Rampulla M S, Bell S C, Klanbest D H, Tobia A J, Falotica R, Heartlein B, Weiss C L & Moore J B, J Med Chem, 33, 1990, 380.
9. b) Reddy Sasstry C V, Srinivasa Rao K, Krishnan V S H, Rastogi K, Jain M L, Verma R K, Tripathi R M, Singh P P, Seshagiri Rao C & Kaushal R, Indian J Chem, 28B, 1989, 882.
10. Yanzhu B & Scarborough R M, in Recent advances in Anticoagulant agents. Annual reports in medicinal chemistry, Chapter 9, 35, 2000, 83.
11. a) Venkatesh Kumar T, Srinivasa Rao K, Lakshmi Narayana V, Dubey P K & Aparna V, Heterocyclic Communications, 9(1), 2003, 51.
12. b) Reddy P S N, Pragati Reddy, Jagath Reddy G & Srinivasa Rao K, Heterocyclic Communications. 9(5), 2003, 503.
13. Copeland R A, Williams J M, Giannaras J, Nürnberg S, Covington M, Pinto D, Pick S & Trzaskos J M, Pro Nat Acad Sci, USA, 91, 1994, 11202.